RDY · Dr Reddys Laboratories Ltd · Documents

$14.26 +0.11 (+0.74%) Q2 2026 earnings call transcript

Market Cap

$11.73B

833.07M

Volume · Oct 29 169.46K Avg daily vol (3M) 2.92M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
6-K	—	2024-03-22	—
6-K	—	2024-03-19	—
6-K	—	2024-03-15	—
6-K	—	2024-03-14	—
6-K	—	2024-03-14	—
6-K	—	2024-03-13	—
6-K	—	2024-03-12	—
6-K	—	2024-03-04	2024-02-29
6-K	—	2024-03-01	—
6-K	—	2024-02-29	2024-02-28
6-K	—	2024-02-29	—
6-K	—	2024-02-26	—
6-K	—	2024-02-23	2024-02-22
6-K	—	2024-02-21	—
6-K	—	2024-02-20	2024-02-17
6-K	—	2024-02-15	2024-02-14
6-K	—	2024-02-12	—
6-K	—	2024-02-12	2024-02-10
6-K	—	2024-02-05	—
6-K	—	2024-02-02	—
6-K	—	2024-01-31	—
6-K	—	2024-01-30	2024-01-29
6-K	—	2024-01-30	—
6-K	—	2024-01-30	—
6-K	—	2024-01-30	—
6-K	—	2024-01-19	—
6-K	—	2024-01-16	—
6-K	—	2024-01-16	—
6-K	—	2024-01-16	—
6-K	—	2024-01-10	—
6-K	—	2024-01-08	2024-01-05
6-K	—	2024-01-03	—
6-K	—	2024-01-02	—
6-K	—	2024-01-02	—
6-K	—	2023-12-29	—
6-K	—	2023-12-29	—
6-K	—	2023-12-21	—
6-K	—	2023-12-15	2023-12-14
6-K	—	2023-12-12	—
6-K	—	2023-12-11	2023-12-09
6-K	—	2023-12-08	—
6-K	—	2023-12-06	—
6-K	—	2023-12-01	—
6-K	—	2023-11-28	—
6-K	—	2023-11-21	—
6-K	—	2023-11-20	—
6-K	—	2023-11-17	—
6-K	—	2023-11-16	—
6-K	—	2023-11-16	—
6-K	—	2023-11-13	2023-11-10

Showing 351–400 of 746 filings

Key facts CIK 1135951 CUSIP 256135203 13F (30d) 59 filings 54 filers Visit website Investor relations